Recently, the Qingdao Municipal Bureau of Industry and Information Technology released the "First Batch of Qingdao Innovative Product Recommendation Catalogue for 2023". Qingdao Yuanda Biotechnology Co., Ltd. successfully selected two products, "Postbiotics Microecological Skincare Products" and "Lactic Acid Bacteria Postbiotics Intestinal Anti inflammatory Products", from the list of only 77 innovative products, receiving key recommendations. It is also one of the enterprises with the most products selected for this list in the High tech Zone.

The details of the announcement are as follows:

Recommended Catalog of Innovative Products in Qingdao City

Selected for the first batch of 2023

The "Recommended Catalogue of Innovative Products in Qingdao City" is a high-quality product with a high level of innovation selected through multiple stages such as application, review, and public announcement. The innovative products included in the catalog will serve as references for government procurement, enterprise and institution procurement, funding support, and investment decisions of investment and financing institutions. They will also receive assistance in product promotion and industrialization, achieving a dual enhancement of social influence and brand awareness.

The simultaneous selection of two products from Yuanda Biotechnology in the "Qingdao Innovative Product Recommendation Catalogue (First Batch of 2023)" marks another full recognition of Yuanda Biotechnology's ability to transform scientific research and technological achievements. At the same time, it indicates that Yuanda Biotechnology's products represent the direction of advanced technological development, have core independent intellectual property rights, verifiable efficacy, reliable quality and safety, and have great market prospects and promotional application value.

Authoritative recommendation, product strength has reached new heights

Since its establishment, Yuanda Biotechnology has been dedicated to the research and innovation of technology in the field of metagenomics, continuously striving to promote the development of the metagenomics industry and the overall health of the Chinese people. The two products selected for the recommended catalog this time have significant breakthroughs and innovations in related fields.

One of the "Postbiotics Microecological Skincare Products" comes from Bilantera, a Postbiotics skincare ingredient independently developed by Yuanda Biotechnology ® The innovative products developed have obtained three national invention patent authorizations and multiple honors. After more than two years of human clinical trials with thousands of participants (Postbiotics Human Clinical Ethics Filing Number: A202205003), they have passed the world's most rigorous third-party Eurofins safety testing and Postbiotics BILANTERA cytotoxicity testing, and obtained allergen detection patent certificates. They have been professionally validated in terms of efficacy, safety, stability, and quality.

The second "Lactobacillus derived intestinal anti-inflammatory products" refers to PostbioP, a biopharmaceutical product developed by Yuanda Biotech for gastrointestinal care ®- 6 and Postbiocare ®， All of them are prepared based on the scientific research achievements of "key technologies and applications for the preparation of high concentration composite probiotics and their metabolites (prebiotics)" that have already reached the "international leading level", with profound scientific research endorsement and professional technical background.

Especially Postbiocare ®， Yuanda Biotechnology has been breaking through the major problem of gastrointestinal health in China for many years through evidence-based research and development. It is the first genetically modified star product that targets and effectively maintains the gastrointestinal tract. Through experiments, it has been shown that it is a genetically modified preparation with key mechanisms of improving the micro ecological environment of the gastrointestinal tract, inhibiting inflammatory reactions caused by harmful bacteria, enhancing the defense function of the gastrointestinal mucosa, anti Helicobacter pylori, improving superficial gastritis and gastroesophageal reflux. Its significant functional characteristics make it widely applicable in various forms of probiotic foods and medical fields.

In recent years, with the continuous improvement of consumers' health awareness, the emerging market is in a stage of rapid development. As a leader in the emerging industry and a pioneer in micro ecological research, Yuanda Biotechnology has accumulated sufficient targeted scientific research achievements and commercial transformation capabilities, enhancing the unique competitiveness of emerging products, providing customers and users with effective and safe functional emerging terminal product solutions, and better adapting to market changes and development.

At the same time, Yuanda Biotechnology will continue to explore and innovate, enhance the level of industry university research specialization, continue to play a leading role as a model, further build the core advantages of the emerging industry, meet the diversified health needs of the Chinese people, and empower the high-quality development of a healthy China.